Brief: Biora Therapeutics Announces Positive Clinical Trial Results For BT-600
01/07/2024 13:07
July 1 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS ANNOUNCES POSITIVE CLINICAL TRIAL
RESULTS FOR
BT-600
* BIORA THERAPEUTICS INC: BT-600 WAS WELL TOLERATED AND MET
ALL
TRIAL OBJECTIVES
Source text for Eikon: ID:nGNX8LR1Q3
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules